Breakthroughs at Sunnybrook Sunnybrook will transform health care. And we are doing that every day with medical breakthroughs across all of our program areas. Internationally recognized leadership in health care, academic research and education distinguishes Sunnybrook as one of Canada’s premier health sciences centres.
 Sunnybrook Physicist Wins Premier Young Researcher Award
Dr. Charles Cunningham accepted Canada's Premier Young Researcher award at the seventh annual Canadian Health Research Awards gala on November 19th, 2008, held at the National Gallery of Canada in Ottawa.
Click here to read the full press release Learn more about Sunnybrook Research Institute
 Leading-Edge Surgical Technology To Benefit Prostate Cancer Patients
Sunnybrook is to be one of the first Toronto hospitals to adopt a leading-edge surgical robot tool to allow urology surgeons greater minimally-invasive and nerve-sparing approaches in performing radical prostatectomies.
Click here to read the full press release Learn more about Imaging and Surgery
 Image-Guided Ultrasound Targets Cancer
Scientists at Sunnybrook Research Institute (SRI) are developing and commercializing a promising novel therapy for the treatment of prostate cancer that may offer patients a faster and more precise treatment than existing clinical alternatives, with fewer side effects.
Click here to read the full news release Learn more about Odette Cancer Centre
 Canada’s First Hospital-Based HPV Vaccine Clinic Opens at Sunnybrook
The first HPV Vaccine Clinic based in a Canadian hospital has opened its doors. Located at 76 Grenville Street, the Clinic will provide vaccinations, education and counseling for women in order to help reduce the spread of the sexually transmitted HPV infection and, ultimately, the possible onset of cervical cancer.
Click here for more information Learn more about Women & Babies
 Leading Approach to Reduce Over-Treatment of Prostate Cancer To Be Championed Worldwide
Active surveillance, a Canadian-conceived and unprecedented approach to reducing over-treatment and radical treatment side effects in men with low-grade prostate cancer is being championed worldwide with the launch of an international multi-centre study to definitively prove the effectiveness of Surveillance Therapy in a randomized setting.
Click here to read the full press release Learn more about the Odette Cancer Centre
|